Phospho-AKT
Showing 1 - 25 of 295
Head and Neck Squamous Cell Cancer Trial in London (BYL719)
Active, not recruiting
- Head and Neck Squamous Cell Cancer
-
London, Ontario, CanadaLondon Health Sciences Centre, London Regional Cancer Program
Jun 14, 2022
Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))
Completed
- Proteus Syndrome
- MK-7075 (miransertib)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Suspended
- Anatomic Stage III Breast Cancer AJCC v8
- +12 more
- Copanlisib Hydrochloride
- Eribulin Mesylate
-
Gainesville, Florida
- +10 more
Nov 16, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Canada (Laboratory Biomarker Analysis, Pharmacological
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +3 more
-
Calgary, Alberta, Canada
- +4 more
Feb 10, 2022
Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States
Not yet recruiting
- Esophageal Adenocarcinoma
- +2 more
-
Palo Alto, California
- +5 more
Jan 12, 2023
Prostate Cancer Trial in Oxford (Xentuzumab)
Recruiting
- Prostate Cancer
-
Oxford, United KingdomChurchill Hospital, Oxford University Hospitals
Mar 14, 2022
Pancreas Cancer Trial in Scottsdale (Vemurafenib, Sorafenib)
Recruiting
- Pancreas Cancer
-
Scottsdale, ArizonaHonorHealth Research Institute
Oct 28, 2021
Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))
Active, not recruiting
- Kidney Neoplasms
- multiparametric and fat-detection magnetic resonance imaging (MRI)
-
Taoyuan, TaiwanLi-Jen Wang
Nov 9, 2023
Oligometastases Trial in Baltimore (Nelfinavir, Stereotactic Body Radiation (SBRT))
Completed
- Oligometastases
- Nelfinavir
- Stereotactic Body Radiation (SBRT)
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 14, 2021
Barrett Oesophagitis With Dysplasia Trial in Kansas City (Itraconazole in capsule form, Itraconazole in solution form)
Recruiting
- Barrett Oesophagitis With Dysplasia
- Itraconazole in capsule form
- Itraconazole in solution form
-
Kansas City, KansasUniversity of Kansas Medical Center
Nov 1, 2022
Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (Everolimus, Nelarabine, Cyclophosphamide)
Recruiting
- Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Everolimus
- +3 more
-
Atlanta, Georgia
- +3 more
Aug 18, 2022
Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chicago, Illinois
- +15 more
Oct 25, 2021
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Columbus (drug, other, dietary
Active, not recruiting
- Stage I Prostate Cancer
- +3 more
- lyophilized black raspberry confection
- +4 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 21, 2021
Cirrhosis, Liver Trial in Cleveland (Leucine enriched essential amino acid (EEA/LEU), Balanced amino acid supplement (BAA))
Recruiting
- Cirrhosis, Liver
- Leucine enriched essential amino acid (EEA/LEU)
- Balanced amino acid supplement (BAA)
-
Cleveland, OhioCleveland Clinic Foundation
Mar 7, 2022
Cirrhosis, Liver Trial in Cleveland (Hydroxy Methyl Butyrate, Balanced Amino Acids)
Recruiting
- Cirrhosis, Liver
- Hydroxy Methyl Butyrate
- Balanced Amino Acids
-
Cleveland, OhioCleveland Clinic
Dec 8, 2021
Breast Cancer, Prostate Cancer, Advanced Solid Tumors Trial in Middletown, Harrison, New York (AZD5363, Enzalutamide,
Active, not recruiting
- Breast Cancer
- +2 more
- AZD5363
- +2 more
-
Middletown, New Jersey
- +2 more
Jul 5, 2022
Acute Myelogenous Leukemia Trial in Rochester (Decitabine)
Completed
- Acute Myelogenous Leukemia
-
Rochester, New YorkUniversity of Rochester
Jul 1, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Breast Adenocarcinoma, Estrogen Receptor Positive, HER2/Neu Negative Trial in Tampa, Bronx (drug, other, procedure)
Terminated
- Breast Adenocarcinoma
- +8 more
- Cyclophosphamide
- +5 more
-
Tampa, Florida
- +1 more
Sep 22, 2020
Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of
Not yet recruiting
- Triple Negative Breast Cancer
- +2 more
- Everolimus
- Investigator's Choice of Chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 25, 2023